Ibolya Csernak

Ibolya Csernak practices at Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System.

Ibolya Csernak's NPI, 1740743095, was assigned on April 12, 2019. Ibolya Csernak holds South Carolina license 88779.

Ibolya Csernak's primary practice is Spartanburg Medical Center, at 101 E Wood St, Spartanburg, SC 29303 in Spartanburg County. The practice phone is (864) 560-6554.

Ibolya Csernak's primary practice is Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System. Ibolya Csernak is also affiliated with Pelham Medical Center. The medical group on file is Medical Group of the Carolinas - Family Medicine - Converse Heights. Dmand AI also links Ibolya Csernak to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ibolya Csernak practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ibolya Csernak's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Ibolya Csernak is licensed in South Carolina.

CMS data shows 186 Medicare services from Ibolya Csernak across 2 procedure codes in 2024, for 196 Medicare patients. Medicare paid $23,488 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 196 Medicare patients who saw Ibolya Csernak in 2024. The largest group is 75 to 84, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ibolya Csernak's median patient age at 73, with 57% women.

In 2024, Ibolya Csernak wrote 50 Medicare Part D claims for 15 patients. 94% of them were for generic drugs. They cover 12 drugs, with $1,384 in total drug cost. In 2022, CMS named 54 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Ibolya Csernak for performance year 2024, reported through an alternative payment model (APM). Ibolya Csernak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Ibolya Csernak from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $78.